{"id":7796,"date":"2026-02-24T06:08:27","date_gmt":"2026-02-24T06:08:27","guid":{"rendered":"https:\/\/pandapeptides.com\/research\/cjc-1295-with-dac\/"},"modified":"2026-04-29T09:08:58","modified_gmt":"2026-04-29T16:08:58","slug":"cjc-1295-with-dac","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/research\/cjc-1295-with-dac\/","title":{"rendered":"CJC-1295 with DAC \u2014 Published Research"},"content":{"rendered":"<div style=\"max-width:800px;margin:0 auto\">\n<p style=\"color:#a1a1aa;font-size:14px;margin-bottom:30px\"><a href=\"\/es\/producto\/cjc-1295-with-dac\/\" style=\"color:#00e5ff\">\u2190 Back to CJC-1295 with DAC product page<\/a><\/p>\n<section id=\"panda-cjc-dac-research-orientation\" style=\"background:#111827;border-radius:14px;padding:20px 22px;margin:28px 0\">\n<h2 style=\"color:#fafafa;margin:0 0 10px;font-size:24px\">How to read this CJC-1295 with DAC research page<\/h2>\n<p style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px\">This page summarizes CJC-1295 with DAC literature by experimental theme, including albumin-binding chemistry, modified GRF analog design, and model-system pharmacokinetic research. It is a literature map, not a protocol or human-use resource.<\/p>\n<ul style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px 20px\">\n<li><strong style=\"color:#fafafa\">Chemistry focus:<\/strong> references are organized around DAC linker behavior, albumin binding, and receptor-signaling models.<\/li>\n<li><strong style=\"color:#fafafa\">Research framing:<\/strong> summaries describe published experimental models and should not be read as product claims or intended uses.<\/li>\n<li><strong style=\"color:#fafafa\">Documentation links:<\/strong> compare the <a href=\"\/es\/producto\/cjc-1295-with-dac\/\" style=\"color:#00e5ff\">catalog listing<\/a>, <a href=\"\/es\/coa\/\" style=\"color:#00e5ff\">COA hub<\/a>, y <a href=\"\/es\/research-framework\/\" style=\"color:#00e5ff\">research framework<\/a>.<\/li>\n<\/ul>\n<p style=\"color:#71717a;font-size:13px;line-height:1.6;margin:0\">Panda Peptides products are for research use only. No dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance is provided.<\/p>\n<\/section>\n<div style=\"margin-top:40px;max-width:900px\">\n<h3 style=\"color:#fafafa;font-size:22px;margin-bottom:8px\">Biblioteca de investigaci\u00f3n<\/h3>\n<p style=\"color:#71717a;font-size:13px;margin-bottom:20px\">Published research on CJC-1295 with DAC \u2014 for educational purposes only<\/p>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">Drug Affinity Complex (DAC) Albumin-Binding Technology<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>The DAC technology utilizes a reactive maleimide linker attached to the peptide that covalently binds to Cys34 of circulating serum albumin. This prevents glomerular filtration (albumin MW ~66 kDa exceeds renal threshold) and protects the peptide from proteolysis. The conjugation reaction is essentially irreversible under physiological conditions. Pharmacokinetic studies in animal models show that &gt;90% of CJC-1295-DAC becomes albumin-bound within minutes. For laboratory research use only.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Jette L et al. &#8220;hGRF(1-29)-albumin bioconjugates activate GRF receptor signaling in rat models.&#8221; <em>Endocrinology.<\/em> 2005. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15817669\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">Receptor pharmacology overview<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>CJC-1295 is a modified GRF(1-29) analog that activates a class B receptor pathway in pituitary models. Receptor activation stimulates G\u03b1s-mediated cAMP signaling and downstream secretory responses. The four amino acid substitutions (Ala2, Gln8, Ala15, Leu27) confer resistance to DPP-IV cleavage and improve receptor binding affinity compared to native GRF(1-29). For laboratory research use only.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Teichman SL et al. &#8220;Prolonged signaling effects of CJC-1295, a long-acting GRF analog.&#8221; <em>J Clin Endocrinol Metab.<\/em> 2006. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16352683\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">CJC-1295 in GRF-knockout mouse models<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>Studies using GRF-knockout mice\u2014which have severe GH deficiency, dwarfism, and virtually undetectable IGF-1\u2014demonstrated that CJC-1295 exposure partially restored somatic growth. Exposure increased body weight, femur length, and pituitary GH mRNA expression. The results confirmed that the somatotroph population in GRF-KO mice retained functional target receptors capable of responding to exogenous GRF analogs despite the absence of endogenous upstream peptide signaling. For laboratory research use only.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Alba M et al. &#8220;Exposure of CJC-1295, a long-acting GRF analog, normalizes growth in the GRF-knockout mouse.&#8221; <em>Am J Physiol Endocrinol Metab.<\/em> 2006. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16822960\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n<div class=\"panda-research-next-card\" style=\"margin:28px 0 0;padding:20px;background:#111113;border:1px solid #27272a;border-radius:14px;color:#a1a1aa;font-size:14px;line-height:1.65\">\n<h3 style=\"margin:0 0 10px;color:#fafafa;font-size:18px;line-height:1.3\">Continue reviewing CJC-1295 with DAC<\/h3>\n<p style=\"margin:0 0 14px\">Use the research references above alongside Panda\u2019s batch documentation and catalog specifications.<\/p>\n<div style=\"display:flex;flex-wrap:wrap;gap:10px\"><a href=\"\/es\/producto\/cjc-1295-with-dac\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">View product specs<\/a><a href=\"\/es\/coa\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">Check COA library<\/a><a href=\"\/es\/quality-and-testing\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#d946ef;text-decoration:none;border:1px solid #27272a\">Quality &amp; testing<\/a><a href=\"\/es\/research-framework\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">Evaluation guide<\/a><a href=\"\/es\/research\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#a1a1aa;text-decoration:none;border:1px solid #27272a\">Research library<\/a><\/div>\n<\/div>\n<div style=\"margin-top:30px;padding:20px;background:#18181b;border-radius:10px;color:#71717a;font-size:13px\">\n<p><strong>Disclaimer:<\/strong> All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use only. This page is provided for research-reference and documentation review only.<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2190 Back to CJC-1295 with DAC product page How to read this CJC-1295 with DAC research page This page summarizes CJC-1295 with DAC literature by experimental theme, including albumin-binding chemistry, modified GRF analog design, and model-system pharmacokinetic research. It is a literature map, not a protocol or human-use resource. Chemistry focus: references are organized around [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7796","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/comments?post=7796"}],"version-history":[{"count":5,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7796\/revisions"}],"predecessor-version":[{"id":9501,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7796\/revisions\/9501"}],"up":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7787"}],"wp:attachment":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/media?parent=7796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}